Cystic Fibrosis

April 8, 2016April 8, 2016

Laurent Pharmaceuticals’ Drug Candidate for Cystic Fibrosis Supported by Anges Québec, Other Investors

Cystic Fibrosis, News

A series of Canadian so-called angel investors, primarily Anges Québec, are partnering with Aligo Innovation and other private investors to help Cystic Fibrosis Canada support the growth of Laurent Pharmaceuticals, a Montreal-based private biopharma ... Read more

April 6, 2016April 6, 2016

Arch Biopartners Licenses Drug Candidate to Treat CF Lung Infections

Cystic Fibrosis, News

Arch Biopartners, Inc., recently announced that it has entered an exclusive license agreement with the University of Cincinnati (UC) for commercial rights to UC’s AB569, a drug candidate for the ... Read more

April 4, 2016April 4, 2016

Kids with Cystic Fibrosis Often Have Altered Bacterial Flora, Contributing to Symptoms in Gut

Cystic Fibrosis, News

Problems with absorbing nutrients and inflammation of the gut are hallmarks of cystic fibrosis (CF). A University of Washington study now shows that in children with cystic fibrosis, an altered gut ... Read more

April 4, 2016April 4, 2016

Cystic Fibrosis Patients See Potentially Promising Therapies from Proteostasis Therapeutics

Cystic Fibrosis, News

Proteostasis Therapeutics — a pharmaceutical company that develops small molecule drugs for cystic fibrosis (CF) — recently announced the latest pre-clinical results from its first-in-class genotype-agnostic amplifier and a novel corrector of CFTR ... Read more

April 1, 2016April 4, 2016

Two Lives Saved as Stanford Health Team Performs Rare Domino Transplant

Cystic Fibrosis, News

A surgical team at Stanford Health Care, under the leadership of heart surgeon Dr. Joseph Woo, has performed a rare “domino” transplant, saving the lives of two women. The technique has ... Read more

March 31, 2016April 4, 2016

For Preschoolers with Cystic Fibrosis, Clinicians Develop New Guidelines, Clinical Care Recommendations

Cystic Fibrosis, News

A multidisciplinary team of clinicians and researchers created a comprehensive document featuring guidelines and recommendations for the clinical care of preschool children between the ages of 2 and 5 who have ... Read more

March 29, 2016May 13, 2016

Cystic Fibrosis Patients May Have Better Treatment Options with Personalized Medicine

Cystic Fibrosis, News

Personalized medicine may offer better treatment options for highly variable diseases such as cystic fibrosis (CF), where treatments are based on individual factors right down to the molecular level. This is particularly ... Read more

March 24, 2016March 24, 2016

Researchers Build Promising CF Diagnostic System Using Microsoft’s Xbox Kinect Sensors

Cystic Fibrosis, News

In a new study, researchers describe the development of a low-cost and effective chest wall motion assessment system, essential for the rapid and accurate diagnosis of respiratory diseases, that uses ... Read more

March 23, 2016May 13, 2016

Laurent Pharma to Prepare Phase 2 Trial for Cystic Fibrosis on Heels of New Financing Round

Cystic Fibrosis, News

Montreal-based Laurent Pharmaceuticals recently announced the closing of a financing round, led by new investor Cystic Fibrosis Canada. The round included existing investors such as Aligo Innovation LP and Anges Quebec, and ... Read more

March 22, 2016May 13, 2016

FDA Designation to Speed Testing of Inhaled Antibiotic, Levofloxacin, to Treat Lung Infections

Bronchiectasis, Cystic Fibrosis, News

Raptor Pharmaceutical Corp. announced that its proprietary inhaled levofloxacin, MP-376, has been given Qualified Infectious Disease Product (QIDP) designation by the U.S. Food and Drug Administration (FDA) to treat three specific indications: ... Read more